Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
20 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/20/3084908/0/en/ZyVersa-Therapeutics-Highlights-Published-Study-Reinforcing-That-Microglia-driven-Inflammation-Is-Pivotal-in-Development-of-Parkinson-s-and-Alzheimer-s-Diseases.html
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079612/0/en/ZyVersa-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Highlights-Pipeline-Progress.html
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070085/0/en/ZyVersa-Therapeutics-Announces-Published-Data-Showing-Inflammasome-ASC-Inhibitor-IC-100-Decreases-Microglial-Inflammasome-Activation-and-Alpha-Synuclein-That-Contribute-to-Neurodeg.html
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067318/0/en/ZyVersa-Therapeutics-CEO-Issues-Shareholder-Letter-Announcing-Transformative-R-D-Trends-for-Inflammasome-Inhibitors-and-Provides-Update-on-Inflammasome-ASC-Inhibitor-IC-100-s-Devel.html
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057518/0/en/ZyVersa-Therapeutics-CEO-Issues-Shareholder-Letter-on-PARASOL-Recommendations-Expected-to-Reduce-Drug-Development-Barrier-for-Rare-Kidney-Disease-Focal-Segmental-Glomerulosclerosis.html
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050628/0/en/ZyVersa-Therapeutics-Reports-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html
ABOUT THIS PAGE